Clinical trial
Alefacept (Amevive) With or Without Narrowband UVB Treatment in Patients With…
NCT00407342 · Medical University of Graz, Other · Completed
Key facts
| NCT number | NCT00407342 |
|---|---|
| Title | Alefacept (Amevive) With or Without Narrowband UVB Treatment in Patients With Psoriasis. |
| Official title | Prospective, Randomized Half-side Comparison of Alefacept (Amevive) With or Without UVB-311nm Phototherapy in Patients With Psoriasis (Translated From German) |
| Lead sponsor | Medical University of Graz, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug, Procedure |
| Interventions | Alefacept (drug), Narrowband UVB phototherapy |
| Enrollment | 14 |
| Start date | Feb 1, 2004 |
| Primary completion | Jun 1, 2004 |
| Completion | Sep 1, 2004 |
| First posted | Dec 5, 2006 |
| Last update posted | Sep 30, 2009 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: